It is well-established that angiotensin II promotes insulin resistance, de novo lipogenesis, and pro-inflammatory cytokine production, and triggers liver inflammation and fibrogenesis [142], while active angiotensin 1–7 signal inhibits liver lipogenesis, fatty acid oxidation, inflammation, and fibrosis [143]. The gene discussed is AGT; the disease is Insulin resistance.